naphthalenesulfonamide has been researched along with 2-naphthylamide in 1 studies
| Studies (naphthalenesulfonamide) | Trials (naphthalenesulfonamide) | Recent Studies (post-2010) (naphthalenesulfonamide) | Studies (2-naphthylamide) | Trials (2-naphthylamide) | Recent Studies (post-2010) (2-naphthylamide) |
|---|---|---|---|---|---|
| 16 | 0 | 4 | 36 | 1 | 18 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brazzolotto, X; Brus, B; Colletier, JP; Coquelle, N; Gobec, S; Knez, D; Kos, J; Košak, U; Nachon, F; Pišlar, A | 1 |
1 other study(ies) available for naphthalenesulfonamide and 2-naphthylamide
| Article | Year |
|---|---|
N-Propargylpiperidines with naphthalene-2-carboxamide or naphthalene-2-sulfonamide moieties: Potential multifunctional anti-Alzheimer's agents.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Butyrylcholinesterase; Cell Death; Cell Line; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Humans; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Naphthalenes; Peptide Fragments; Piperidines; Structure-Activity Relationship; Sulfonamides | 2017 |